Keyphrases
Glioblastoma
100%
Clinical Protocols
100%
Posaconazole
100%
Neuropharmacological Study
100%
Hexokinase
36%
Tumor Samples
27%
Lactate
18%
Glycolysis
18%
Dialysate
18%
Neuropharmacological
18%
Tumor Metabolism
18%
Plasma Samples
9%
Tumor
9%
Microdialysis
9%
Brain Regions
9%
Angiogenesis
9%
Apoptosis
9%
Interstitium
9%
Area under the Curve
9%
Mouse Survival
9%
Contrast Enhancement
9%
Therapeutic Potential
9%
Time-area
9%
Penetrance
9%
Lactate Production
9%
Poor Prognosis
9%
Inverse Correlation
9%
Oncogenic Pathways
9%
Primary Brain Tumor
9%
Repurposing
9%
Time Profile
9%
Brain Tumor
9%
Catheter Placement
9%
Profile Effects
9%
{2}-inverse
9%
Non-enhancing
9%
Phase Trials
9%
Tumor Resection
9%
Mechanistic Effect
9%
Advanced Phase
9%
Immunology and Microbiology
Tumor Cell
100%
Cell Metabolism
100%
Blood Plasma
50%
Arm
50%
Interstitium
50%
Angiogenesis
50%
Microdialysis
50%
Penetrance
50%
Brain Region
50%
Programmed Cell Death
50%
Medicine and Dentistry
Clinical Trial
100%
Glioblastoma
100%
Posaconazole
100%
Neoplasm
45%
Hexokinase
36%
Lactic Acid
27%
Pyruvic Acid
27%
Tumor Cell
18%
Cell Metabolism
18%
Dialysis Fluid
18%
Angiogenesis
9%
Arm
9%
Programmed Cell Death
9%
Cancer Surgery
9%
Interstitium
9%
Penetrance
9%
Brain Region
9%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Glioblastoma
100%
Posaconazole
100%
Neoplasm
72%
Hexokinase
36%
Lactic Acid
27%
Pyruvic Acid
27%
Dialysis Fluid
18%
Intracranial Tumor
18%
Microdialysis
9%
Neuroscience
Posaconazole
100%
Hexokinase
36%
Metabolic Pathway
18%
Angiogenesis
9%
Programmed Cell Death
9%